Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × GSK 1363089 × Clear all

NCT02034097 2014-05-19

A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Neoplasms